Eleni Korompoki - Concepedia

Author

Eleni Korompoki

National and Kapodistrian University of Athens ORCID

Also Known As

E Korompoki, E. Korompoki, Eleni Korompoki, Korompoki Eleni, Korompoki, Eleni

117

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Alexandra Hospital Imperial College London University of Thessaly Oslo University Hospital

About

Eleni Korompoki is an author at National and Kapodistrian University of Athens specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	733
2	Public Health	6	6	394
3	Epidemiology	3	3	260
4	Health Sciences	2	2	41
5	Emergency Medicine	1	1	58

Eleni Korompoki

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke George Ntaios, Patrik Michel, Georgios Georgiopoulos, Stroke	2020	279
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline Catharina J.M. Klijn, Maurizio Paciaroni, Eivind Berge, European Stroke Journal Heart FailureNon-valvular Atrial FibrillationCerebrovascular DiseasePharmacotherapyThrombosis	2019	193
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados, The Lancet Neurology	2018	177
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018 Niaz Ahmed, Heinrich J. Audebert, Guillaume Turc, European Stroke Journal	2019	168
Age‐dependent and gender‐dependent antibody responses against <scp>SARS‐CoV</scp>‐2 in health workers and octogenarians after vaccination with the <scp>BNT162b2 mRNA</scp> vaccine Evangelos Terpos, Ioannis P. Trougakos, Filia Apostolakou, American Journal of Hematology VaccinationVaccine SafetyVaccinologyHealth WorkersVaccine Development	2021	156
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis George Ntaios, Balakumar Swaminathan, Scott D. Berkowitz, Stroke HypertensionCerebrovascular DiseasePharmacotherapyRivaroxaban Versus AspirinThrombosis	2019	86
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial George Ntaios, Lesly A. Pearce, Roland Veltkamp, Stroke	2020	75
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors Evangelos Terpos, Dimitris Stellas, Margherita Rosati, European Journal of Internal Medicine Viral PersistenceConvalescent Plasma DonorsCovid-19 PandemicSpike AntibodiesImmunology	2021	71
European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke Valeria Caso, Guillaume Turc, Azmil H. Abdul‐Rahim, European Stroke Journal	2024	68
Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS score George Ntaios, Kalliopi Perlepe, Dimitris Lambrou, International Journal of Stroke	2020	65

Page 1